ANAVEX LIFE SCIENCES CORP. Shareholders' Equity
ANAVEX LIFE SCIENCES CORP. (AVXL) had Shareholders' Equity of $112.45 million as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-28
- 2026-06-30: Stockholders' Equity Attributable to Parent $112.45M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $121.71M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $126.62M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $94.87M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $112.45M 10-Q · filed 2026-08-28 | |
| 2026-03-31 | $121.71M 10-Q · filed 2026-08-28 | |
| 2025-12-31 | $126.62M 10-Q · filed 2026-08-28 | |
| 2025-09-30 | $94.87M 10-K/A · filed 2026-08-28 | |
| 2025-06-30 | $90.96M 10-Q · filed 2026-08-28 | |
| 2025-03-31 | $99.76M 10-Q · filed 2026-08-28 | |
| 2024-12-31 | $110.92M 10-Q · filed 2026-08-28 | |
| 2024-09-30 | $120.26M 10-K/A · filed 2026-08-28 | |
| 2024-06-30 | $129.78M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $134.96M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $135.57M 10-Q · filed 2025-05-13 | |
| 2023-09-30 | $141.85M 10-K/A · filed 2026-08-28 | |
| 2023-06-30 | $146.75M 10-Q · filed 2024-08-06 | $146.75M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $145.16M 10-Q · filed 2024-08-06 | $145.17M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $135.12M 10-Q · filed 2024-05-09 | $135.12M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $142.49M 10-K/A · filed 2026-08-28 | $142.49M 10-K · filed 2022-11-28 |
| 2022-06-30 | $150.74M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $152.21M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $146.37M 10-Q · filed 2023-05-09 | |
| 2021-09-30 | $150.82M 10-K · filed 2023-11-27 | $150.82M 10-K · filed 2021-11-24 |
| 2021-06-30 | $157.15M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $75.81M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $46.30M 10-Q · filed 2022-05-10 | |
| 2020-09-30 | $27.24M 10-K · filed 2023-11-27 | $27.24M 10-K · filed 2020-12-28 |
| 2020-06-30 | $24.68M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $24.79M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $25.96M 10-Q · filed 2021-05-13 | |
| 2019-09-30 | $20.29M 10-K · filed 2022-11-28 | |
| 2019-06-30 | $21.19M 10-Q · filed 2020-08-06 | $17.63M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $17.18M 10-Q · filed 2020-08-06 | $14.18M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $19.46M 10-Q · filed 2020-05-07 | $17.22M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $22.32M 10-K · filed 2020-12-28 | $20.49M 10-K · filed 2018-12-12 |
| 2018-06-30 | $23.59M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $22.48M 10-Q · filed 2019-08-07 | |
| 2017-12-31 | $25.55M 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $25.88M 10-K · filed 2019-12-16 | $24.25M 10-K · filed 2017-12-11 |
| 2017-06-30 | $23.45M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $21.49M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $19.18M 10-Q · filed 2017-02-07 | |
| 2016-09-30 | $6.31M 10-K · filed 2019-01-25 | |
| 2016-06-30 | $7.67M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $9.68M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $11.49M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $12.81M 10-K · filed 2019-01-25 | |
| 2015-06-30 | $6.57M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $4.70M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $473.13K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $192.63K 10-K · filed 2017-12-11 | |
| 2014-06-30 | $7.41M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $8.41M 10-Q/A · filed 2014-05-30 | |
| 2013-12-31 | -$1.67M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$2.46M 10-K · filed 2016-12-14 | |
| 2013-06-30 | -$3.55M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$3.43M 10-Q · filed 2013-05-17 | |
| 2012-12-31 | -$3.33M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | -$2.88M 10-K · filed 2014-12-29 | |
| 2012-06-30 | -$2.20M 10-Q · filed 2012-08-17 | |
| 2012-03-31 | -$2.93M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$2.48M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$1.14M 10-Q/A · filed 2014-05-30 | |
| 2011-06-30 | -$973.45K 10-Q · filed 2011-08-12 | |
| 2010-09-30 | -$2.96M 10-Q/A · filed 2014-05-30 | |
| 2009-09-30 | -$3.86M 10-Q/A · filed 2014-05-30 | |
| 2008-09-30 | -$2.29M 10-Q/A · filed 2014-05-30 | |
| 2007-09-30 | -$462.50K 10-Q/A · filed 2014-05-30 | |
| 2006-09-30 | -$15.51K 10-Q/A · filed 2014-05-30 | |
| 2005-09-30 | -$26.02K 10-Q/A · filed 2014-05-30 | |
| 2004-09-30 | $25.61K 10-Q/A · filed 2014-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |